ROCK HILL, S.C., March 10, 2016 - 3D Systems Corporation (NYSE:DDD) announced today that it has rescheduled its conference call to discuss its financial results for the fourth quarter and full year of 2015. The company plans to hold this conference call and webcast on Monday, March 14, 2016, at 8:30 a.m. Eastern Time.
The company plans to release its fourth quarter and full year 2015 financial results and file its Form 10-K on March 14, 2016.
Fourth Quarter and Full Year 2015 Conference Call
Date: Monday, March 14, 2016
Time: 8:30 a.m. Eastern Time
Listen via Internet: www.3dsystems.com/investor
Participate via telephone:
Within the U.S.: 1-877-407-8291
Outside the U.S.: 1-201-689-8345
The recorded webcast will be available beginning approximately two hours after the live presentation at www.3dsystems.com/investor.
Forward-Looking Statements
Certain statements made in this release that are not statements of historical or current facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as “believes,” “belief,” “expects,” “estimates,” “intends,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may include comments as to the company’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to uncertainties, many of which are outside the control of the company. The factors described under the headings “Forward-Looking Statements,” “Cautionary Statements and Risk Factors,” and “Risk Factors” in the company’s periodic filings with the Securities and Exchange Commission, as well as other factors, could cause actual results to differ materially from those reflected or predicted in forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. 3D Systems undertakes no obligation to update or revise any forward-looking statements, even if experience or future changes make it clear that projected results expressed or implied in such statements will not be realized, except as may be required by law.
About 3D Systems
3D Systems provides comprehensive 3D products and services, including 3D printers, print materials, on-demand manufacturing services and digital design tools. Its ecosystem supports advanced applications from the product design shop to the factory floor to the operating room. 3D Systems’ precision healthcare capabilities include simulation, Virtual Surgical Planning, and printing of medical and dental devices as well as patient-specific surgical instruments. As the originator of 3D printing and a shaper of future 3D solutions, 3D Systems has spent its 30 year history enabling professionals and companies to optimize their designs, transform their workflows, bring innovative products to market and drive new business models.


Toyota Global Sales Fall for Seventh Month as China Demand Slumps
Lindt Slashes 2026 Sales Growth Forecast as European Demand Weakens
Grayscale Sees Zcash Gaining Market Share Against Bitcoin
Anthropic Targets $2 Trillion Valuation in Planned IPO
Pepco Raises FY26 Earnings Outlook, Unveils €400 Million Buyback
CSL Partners With AWS to Bring AI Into Drug Research
BlackRock Sees AI Agents Fueling New Crypto Demand
Google Pays Publishers for AI Search Content in New Pilot
Robinhood Chain Meme Coins Slide as Stock Token Locks Rise
QNT Whales Move $10M to Exchanges After 400% Rally
Strategy Buys 1,665 Bitcoin as BTC Holdings Reach 847,666
Goldman Sachs Private Credit Fund Sees Redemptions Ease in Q3
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo
Robinhood Launches AI Agents for Automated Trading
Aztec Revives zk.money for Private Ethereum Payments 



